Aytu Biopharma (AYTU) Liabilities and Shareholders Equity (2011 - 2026)
Aytu Biopharma (AYTU) posted Liabilities and Shareholders Equity of $105.01 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 15.4% from $124.18 million a year earlier and down 6.0% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Since fiscal Q4 2011, Aytu Biopharma has reported Liabilities and Shareholders Equity for 57 quarters.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -16.9% (FY2021 to FY2026).
- In prior fiscal years, Aytu Biopharma's Liabilities and Shareholders Equity was $124.18 million in FY2025 (+5.2%), $118.1 million in FY2024 (-13.5%), $136.46 million in FY2023 (-0.8%) and $137.62 million in FY2022 (-48.2%).
- The fiscal Q4 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since fiscal Q2 2020.
- On a year-over-year basis, Liabilities and Shareholders Equity increased in three of the last eight quarters, with an average decline of 4.4%.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was fiscal Q1 2022, with growth of 61.2%; the weakest was fiscal Q4 2022, with a decline of 48.2%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior fiscal quarters was $111.69 million (Q3 2026), $122 million (Q2 2026) and $124.99 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Aytu Biopharma | 23.25 Mn | -92.42 Mn | 10.41 Mn | 105.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 105.01 Mn |
| Mar 31, 2026 | 111.69 Mn |
| Dec 31, 2025 | 122.00 Mn |
| Sep 30, 2025 | 124.99 Mn |
| Jun 30, 2025 | 124.18 Mn |
| Mar 31, 2025 | 124.20 Mn |
| Dec 31, 2024 | 116.23 Mn |
| Sep 30, 2024 | 115.83 Mn |
| Jun 30, 2024 | 118.10 Mn |
| Mar 31, 2024 | 128.86 Mn |
| Dec 31, 2023 | 131.25 Mn |
| Sep 30, 2023 | 132.89 Mn |
| Jun 30, 2023 | 136.46 Mn |
| Mar 31, 2023 | 147.22 Mn |
| Dec 31, 2022 | 141.44 Mn |
| Sep 30, 2022 | 150.00 Mn |
| Jun 30, 2022 | 137.62 Mn |
| Mar 31, 2022 | 168.83 Mn |
| Dec 31, 2021 | 223.82 Mn |
| Sep 30, 2021 | 227.73 Mn |
API Access
Aytu Biopharma Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();